MarketInOut Stock Screener Log In | Sign Up
 

Sernova Biotherapeutics Inc

TSX • Healthcare • Biotechnology • Quote as of 09/08/2026 15:56
Sernova Biotherapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeTSX
Market Capitalization41.54 mln
Float327 mln
Earnings Date09/10/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

99 / 100
Top performer

Debt / Equity

-0.25
Negative equity

Dividend Yield

0.00%
No dividend

DPS

0.00
No dividend

Payout Ratio

0%
No payout

Business Description

Sernova Biotherapeutics is a Canadian medical company working to develop treatments that use living cells to restore natural body functions lost to disease. Its core technology, the Cell Pouch, is a small implantable device that creates a stable, blood-supplied environment where therapeutic cells can survive and function long-term, while remaining retrievable if needed. Based in Mississauga, the company was previously known as Sernova Corp before adopting its current name in early 2025.

Key Fundamentals

EPS-0.04
ROIC-116
ROA-731
EBITDA, mln-10.01
EV / EBITDA-5.49
EV / EBIT-5.36

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio0.24

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 18.18% 99 / 100   
1 Month 13.04% 91 / 100   
2 Months -16.13% 7 / 100   
6 Months -23.53% 6 / 100   
1 Year -33.33% 6 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us